Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

UREA

×

Overview

What is Keralac?

Each gram contains 470 mg of urea in a vehicle consisting of: camphor, disodium EDTA, alcohol SDA 40, eucalyptus oil, hydroxyethylcellulose, menthol, water and titanium dioxide.

Urea is a diamide of carbonic acid with the following chemical structure:



What does Keralac look like?



What are the available doses of Keralac?

Sorry No records found.

What should I talk to my health care provider before I take Keralac?

Sorry No records found

How should I use Keralac?

This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratosis and calluses.

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.


What interacts with Keralac?

Sorry No Records found


What are the warnings of Keralac?

Sorry No Records found


What are the precautions of Keralac?

Sorry No Records found


What are the side effects of Keralac?

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.


What should I look out for while using Keralac?

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

WARNINGS: KEEP OUT OF REACH OF CHILDREN.


What might happen if I take too much Keralac?

Sorry No Records found


How should I store and handle Keralac?

Storage and HandlingDispense in a tight container with child-resistant closure.Store at 20°C to 25ºC (68°F to 77ºF); excursions permitted from 15°C to 30ºC (59°F to 86ºF) .The pharmacist should provide an oral dosing device or other suitable measuring device.Storage and HandlingDispense in a tight container with child-resistant closure.Store at 20°C to 25ºC (68°F to 77ºF); excursions permitted from 15°C to 30ºC (59°F to 86ºF) .The pharmacist should provide an oral dosing device or other suitable measuring device.Storage and HandlingDispense in a tight container with child-resistant closure.Store at 20°C to 25ºC (68°F to 77ºF); excursions permitted from 15°C to 30ºC (59°F to 86ºF) .The pharmacist should provide an oral dosing device or other suitable measuring device.Storage and HandlingDispense in a tight container with child-resistant closure.Store at 20°C to 25ºC (68°F to 77ºF); excursions permitted from 15°C to 30ºC (59°F to 86ºF) .The pharmacist should provide an oral dosing device or other suitable measuring device.5 oz. (142 g) bottles, 57883-401-05 To reportManufactured for: MISSION PHARMACAL COMPANY San Antonio, TX 78230 1355 5 oz. (142 g) bottles, 57883-401-05 To reportManufactured for: MISSION PHARMACAL COMPANY San Antonio, TX 78230 1355 5 oz. (142 g) bottles, 57883-401-05 To reportManufactured for: MISSION PHARMACAL COMPANY San Antonio, TX 78230 1355


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

Pharmacokinetics:

Non-Clinical Toxicology
This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

WARNINGS: KEEP OUT OF REACH OF CHILDREN.

Drug Interactions:

When other potent parenteral antihypertensive drugs, such as diazoxide, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure. Profound hypotensive episodes may occur when diazoxide injection and hydralazine injection are used concomitantly.

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

General:

Information for Patients:

Carcinogenesis, Mutagenesis and Impairment of Fertility:

Pregnancy:

Category C.

Nursing Mothers:

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).